<- Go Home
HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Market Cap
EUR 98.0M
Volume
1.2K
Cash and Equivalents
EUR 13.9M
EBITDA
EUR 9.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 19.7M
Profit Margin
7.56%
52 Week High
EUR 20.80
52 Week Low
EUR 15.00
Dividend
6.40%
Price / Book Value
0.66
Price / Earnings
10.00
Price / Tangible Book Value
1.69
Enterprise Value
EUR 87.2M
Enterprise Value / EBITDA
8.45
Operating Income
EUR 9.2M
Return on Equity
6.51%
Return on Assets
3.22
Cash and Short Term Investments
EUR 13.9M
Debt
EUR 3.1M
Equity
EUR 149.4M
Revenue
EUR 260.8M
Unlevered FCF
EUR 5.0M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium